1. Home
  2. MDXG vs NTST Comparison

MDXG vs NTST Comparison

Compare MDXG & NTST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXG
  • NTST
  • Stock Information
  • Founded
  • MDXG 2006
  • NTST 2019
  • Country
  • MDXG United States
  • NTST United States
  • Employees
  • MDXG N/A
  • NTST N/A
  • Industry
  • MDXG Biotechnology: Pharmaceutical Preparations
  • NTST Real Estate Investment Trusts
  • Sector
  • MDXG Health Care
  • NTST Real Estate
  • Exchange
  • MDXG Nasdaq
  • NTST Nasdaq
  • Market Cap
  • MDXG 1.2B
  • NTST 1.2B
  • IPO Year
  • MDXG N/A
  • NTST 2020
  • Fundamental
  • Price
  • MDXG $7.60
  • NTST $15.86
  • Analyst Decision
  • MDXG Strong Buy
  • NTST Strong Buy
  • Analyst Count
  • MDXG 3
  • NTST 7
  • Target Price
  • MDXG $12.00
  • NTST $17.75
  • AVG Volume (30 Days)
  • MDXG 535.9K
  • NTST 881.6K
  • Earning Date
  • MDXG 04-29-2025
  • NTST 04-28-2025
  • Dividend Yield
  • MDXG N/A
  • NTST 5.29%
  • EPS Growth
  • MDXG N/A
  • NTST N/A
  • EPS
  • MDXG 0.28
  • NTST N/A
  • Revenue
  • MDXG $348,879,000.00
  • NTST $162,784,000.00
  • Revenue This Year
  • MDXG $10.09
  • NTST $10.40
  • Revenue Next Year
  • MDXG $11.77
  • NTST $9.61
  • P/E Ratio
  • MDXG $26.93
  • NTST N/A
  • Revenue Growth
  • MDXG 8.52
  • NTST 23.41
  • 52 Week Low
  • MDXG $5.47
  • NTST $13.42
  • 52 Week High
  • MDXG $10.14
  • NTST $18.97
  • Technical
  • Relative Strength Index (RSI)
  • MDXG 38.98
  • NTST 69.03
  • Support Level
  • MDXG $7.84
  • NTST $15.24
  • Resistance Level
  • MDXG $8.12
  • NTST $15.45
  • Average True Range (ATR)
  • MDXG 0.24
  • NTST 0.31
  • MACD
  • MDXG -0.02
  • NTST 0.05
  • Stochastic Oscillator
  • MDXG 24.05
  • NTST 75.59

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

About NTST NetSTREIT Corp.

Netstreit Corp is an internally managed real estate investment trust. The company acquires, owns, and manages single-tenant, retail commercial real estate subject to long-term net leases with high-credit quality tenants across the United States. It focuses on tenants in industries where a physical location is critical to the generation of sales and profits, with a focus on necessity goods and essential services in the retail sector, including home improvement, auto parts, drug stores and pharmacies, general retail, grocers, convenience stores, discount stores, and quick-service restaurants. Majorily operates in U.S. States and Other counties, and derives maximum of revenue from USA.

Share on Social Networks: